OS1.5 Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers
Houtan Noushmehr(Henry Ford Health System), Ana Valeria Castro(Henry Ford Health System), Tobias Walbert(Henry Ford Health System), Dhananjay Chitale(Henry Ford Hospital), Michael Wells(Henry Ford Health System), Abir Mukherjee(University of Chicago), Adam Robin(Ford Motor Company (United States)), Jason R. Rock(Gene Therapy Laboratory), Kimberly M. Nelson(Henry Ford Health System), Tom Mikkelsen(Henry Ford Health System), Ana C. deCarvalho(Henry Ford Hospital), Laila Poisson, Tathiane M. Malta(Henry Ford Health System), Karam Asmaro(Harvard University), Maritza Mosella(Henry Ford Health System), Mark L. Rosenblum(Henry Ford Health System), Thaís S. Sabedot(Universidade de Ribeirão Preto), J Snyder(Henry Ford Health System), Steven N. Kalkanis(Henry Ford Health System)
Cited by 2
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
|Nucleic Acids Research|2015|4.5k